Similar articles

• [Hepatitis B and the delta agent].

  Jilg W, Roggendorf M, Zoulek G, Schlipköter U, Deinhardt F. Jilg W, et al. Fortschr Med. 1984 Feb 9;102(6):119-21. Fortschr Med. 1984. PMID: 6706267 German.
• Hepatitis B virus gene products as immunological targets in chronic infection.

  Feitelson MA. Feitelson MA. Mol Biol Med. 1989 Oct;6(5):367-93. Mol Biol Med. 1989. PMID: 2696858 Review.
• Hepatitis B.

  Otsuka T, Niho Y. Otsuka T, et al. Biomed Pharmacother. 1985;39(9-10):464-6. Biomed Pharmacother. 1985. PMID: 3833306
• [Serological markers of hepatitis B virus in chronic hepatitis and cirrhosis].

  Rull S, Ruiz-Capellán R, Araiz J, Panizo A, Serrano M, Prieto-Valtueña J. Rull S, et al. Rev Esp Enferm Apar Dig. 1985 Apr;67(4):321-5. Rev Esp Enferm Apar Dig. 1985. PMID: 4001527 Spanish. No abstract available.
• [Recent advance in the study of immunopathobiology of hepatitis B virus infection using HBV transgenic mice].

  Kakimi K. Kakimi K. Nihon Rinsho. 2004 Aug;62 Suppl 8:54-7. Nihon Rinsho. 2004. PMID: 15453285 Review. Japanese. No abstract available.